|Podcasts|December 9, 2022
Achieving Success in the Rare Disease Space
Author(s)Nicholas Saraceno, Senior Editor
Lessons learned around commercializing new products in this niche sector
Advertisement
Andy Udell, North American president at Calliditas Therapeutics, a specialty pharma company, uncovers the complexities surrounding rare disease product commercialization, while also shedding light on outreach strategies that help spread awareness of new medications.
The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Have 503B Outsourcing Facilities Truly Reduced US Drug Shortages?
2
The Silent Shift in Pharma Supply Chains
3
FAQ: Decoding Alternative Funding Programs
4
Pharma Pulse: HHS Bypasses PBMs and the Reality of GLP-1 Weight Regain
5